Dongsung Pharmaceutical Decides to Cancel 250,000 Common Shares Under Rehabilitation Plan
- For debt restructuring, 250,000 common shares held by Lee (all) will be cancelled without compensation; cancellation date is May 14, 2026.
- This capital reduction is an implementation measure under the rehabilitation plan approved by Seoul Bankruptcy Court (March 27, 2026); no need for shareholder meeting or board resolution.
- The company plans to sequentially issue convertible bonds and corporate bonds upon court approval.
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: [Correction of Description] Report on Major Matters (Decision on Capital Reduction)
- Company: Dongsung Pharmaceutical (002210)
- Submission: Dongsung Pharmaceutical Co., Ltd.
- Receipt: 05-13-2026